NCT07078032Not yet recruiting
A Randomized Controlled Trial Evaluating the Effectiveness of a Novel Risk-Stratified Screening Strategy for Lung Cancer
Source: ClinicalTrials.gov · Last updated 22 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A nationwide population-based multi-center RCT enrolling ≥60,000 eligible residents to compare screening effectiveness between risk-prediction-model-driven and traditional guideline-based high-risk lung cancer screening strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60000 (estimated)
- First submitted
- 12 Jul 2025
- Start date
- Jul 2025
- Primary completion date
- Jul 2028
- Lead sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Diseases
- Lung cancer
- NCT number
- NCT07078032
What you commit to
- Study type: Interventional
- Planned participants: 60000
- From Jul 2025 to the primary completion date, Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior diagnosis of lung cancer (histologically/cytologically confirmed)
- Currently receiving active treatment for any malignancy.
Other illness
- Participation in any lung cancer screening program within 5 years.
Age
- Presence of severe comorbidities with life expectancy \<5 years
Other
- Functional dependency (ADL score ≤2) OR unwillingness to comply with protocol-required follow-up.
- Declined to provide written informed consent.
Who the study is looking for
- Residents with local household registration residing continuously in the region for ≥3 years.
- Aged 40-74 years at enrollment.
Age in the registry: 40 years to 74 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.